Locations:
Bench-to-bedside study identifies mechanism and potential therapeutic target
A scannable recap of recent volumes and clinical metrics from Cleveland Clinic
Cleveland Clinic reports first U.S. series focused on use in this challenging setting
AVANT GUARD trial extends first-line role for ablation beyond paroxysmal atrial fibrillation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Intracardiac echo mapping of para-septal fat pads provides fast, accurate and radiation-free targeting
Experts discuss advances in precision medicine, the value of collaborative care and more
Scenarios where experience-based management nuance can matter most
Application to flutter found safe and effective in study of 300+ patients
LAA closure may be compelling option in atrial fibrillation ablation patients at high risk of both stroke and bleeding
New analyses confirm preservation of ablation outcomes, broaden data on bleeding benefits
Advertisement
Advertisement
Search